Nitrogen-containing heterocyclic compounds and thrombopoietin receptor activators
申请人:Nissan Chemical Industries, Ltd.
公开号:US08093251B2
公开(公告)日:2012-01-10
Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided.
A compound represented by the formula (I) (wherein R1, R2, R3, L1, L2, L3, X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.